The information on this website is intended for healthcare professionals only and is provided solely for the purpose of scientific exchange. By accessing this website you accept this legal disclaimer and you expressly confirm your status as a healthcare professional.
This website is not country specific and may therefore contain information that is not applicable to your country. The website is not intended to provide medical advice and/or treatment guidance. Therefore, before prescribing any product, always refer to information approved by regulatory authorities in your country such as the prescribing information and/or the Summary of Product Characteristics. Novo Nordisk accepts no liability for the accuracy, completeness or use of information on this website, and disclaims any liability to update the information contained on this website.
Dr Adie Viljoen is a clinical specialist and works as a Consultant
Chemical Pathologist and Metabolic Physician in Hertfordshire, UK,
having trained in South Africa where he received his medical and
specialty medicine qualifications. He conducts clinics in diabetes,
cardiovascular risk prevention, lipid and metabolic disorders and his
interests include type 2 diabetes and diabetic dyslipidaemia,
He is a Senior Lecturer in Medicine at the Bedfordshire and Hertfordshire Postgraduate Medical, and a Member of the Institute for Diabetes in Older People (IDOP). He is the UK Chief Investigator and Principal Site investigator for several international phase 2 and 3 research trials in diabetes, obesity and lipids including studies such as EXAMINE, ORIGIN, 4T, CRESCENDO. He is a member of the Scientific Research Committee of HEART UK and the UK cholesterol charity.